Alector Inc (NASDAQ:ALEC)
| 12.65 BATS BZX Real-Time Price As of Aug 09 |  0.00 / 0.00%Today’s Change | 7.50 Today|||52-Week Range 29.30 | -38.74% Year-to-Date |
Latest ALEC News | Press Releases
| Wall Street Analysts Believe Alector (ALEC) Could Rally 58%: Here's is How to Trade Aug 09 / Zacks.com - Paid Partner Content | Alector (ALEC) Q2 Earnings and Revenues Beat Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.65 |
| Today’s open | 12.85 |
| Day’s range | 12.48 - 13.16 |
| Volume | 26,429 |
| Average volume (3 months) | 633,653 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 08/09/2022
Growth & Valuation
| Earnings growth (last year) | +81.53% |
| Earnings growth (this year) | -259.73% |
| Earnings growth (next 5 years) | -49.85% |
| Revenue growth (last year) | +881.54% |
| P/E ratio | 26.4 |
| Price/Sales | 8.02 |
| Price/Book | 3.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RCKTRocket Pharmaceutica... | +0.54 | +3.33% |
| SRNESorrento Therapeutic... | +0.05 | +1.92% |
| CDMOAvid Bioservices Inc | 0.00 | 0.00% |
| REPLReplimune Group Inc | 0.00 | 0.00% |
Data as of 9:30am ET, 08/10/2022
Financials
| Next reporting date | November 15, 2022 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $207.1M |
| Annual profit (last year) | -$36.3M |
| Net profit margin | -17.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
